Join
Live feed
·
INSIDERFilingvia Quantisnow
InMed Pharmaceuticals Inc. logo

Hull Andrew bought $14,625 worth of shares (37,500 units at $0.39), increasing direct ownership by 4,947% to 38,258 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track INM (InMed Pharmaceuticals Inc.) and more on Quantisnow.